ApicHope Pharmaceutical Co., Ltd
SZSE:300723.SZ
26.51 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 376.961 | 210.408 | 320.632 | 283.646 | 622.871 | 653.636 | 584.1 | 549.709 | 716.002 | 665.339 | 709.753 | 389.4 | 515.707 | 546.018 | 700.015 | 438.424 | 514.757 | 481.348 | 543.362 | 311.387 | 339.32 | 446.298 | 418.069 | 436.883 | 336.155 | 346.255 | 315.717 | 396.55 | 371.033 | 342.364 | 367.235 | 386.788 | 283.83 | 361.615 |
| Cost of Revenue
| 146.832 | 145.574 | 161.916 | 132.376 | 150.913 | 125.835 | 139.723 | 108.247 | 100.775 | 87.854 | 97.203 | 62.723 | 52.425 | 65.851 | 113.3 | 70.946 | 68.365 | 78.198 | 95.471 | 72.7 | 49.059 | 112.761 | 74.776 | 113.671 | 65.822 | 67.303 | 51.279 | 132.083 | 142.807 | 121.348 | 169.84 | 173.391 | 115.331 | 157.794 |
| Gross Profit
| 230.129 | 64.833 | 158.716 | 151.27 | 471.958 | 527.801 | 444.376 | 441.462 | 615.227 | 577.485 | 612.55 | 326.678 | 463.282 | 480.167 | 586.715 | 367.478 | 446.392 | 403.151 | 447.891 | 238.687 | 290.261 | 333.538 | 343.293 | 323.212 | 270.333 | 278.952 | 264.438 | 264.467 | 228.225 | 221.016 | 197.396 | 213.397 | 168.499 | 203.821 |
| Gross Profit Ratio
| 0.61 | 0.308 | 0.495 | 0.533 | 0.758 | 0.807 | 0.761 | 0.803 | 0.859 | 0.868 | 0.863 | 0.839 | 0.898 | 0.879 | 0.838 | 0.838 | 0.867 | 0.838 | 0.824 | 0.767 | 0.855 | 0.747 | 0.821 | 0.74 | 0.804 | 0.806 | 0.838 | 0.667 | 0.615 | 0.646 | 0.538 | 0.552 | 0.594 | 0.564 |
| Reseach & Development Expenses
| 36.642 | 111.344 | 58.104 | 72.988 | 62.529 | 124.717 | 46.399 | 82.13 | 48.122 | 72.605 | 47.108 | 35.825 | 34.243 | 42.659 | 47.032 | 25.571 | 27.061 | 69.01 | 27.765 | 22.201 | 16.368 | 44.866 | 12.959 | 16.188 | 24.035 | 34.278 | 26.198 | 17.841 | 13.066 | 121.274 | 18.336 | 22.719 | 0 | 46.967 |
| General & Administrative Expenses
| 65.554 | -101.164 | 156.902 | -31.708 | 65.777 | -49.799 | 153.047 | -22.775 | 51.418 | 80.952 | 104.081 | -14.116 | 37.704 | -48.01 | 83.895 | -17.079 | 33.706 | -54.157 | 25.099 | -5.204 | 15.637 | -25.557 | 20.921 | -3.813 | 14.076 | -32.34 | 18.839 | -54.795 | 26.77 | -63.12 | 14.182 | -10.871 | 23.058 | -45.986 |
| Selling & Marketing Expenses
| 128.398 | 94.979 | -45.918 | 99.74 | 216.106 | 261.961 | 236.533 | 235.217 | 389.791 | 362.187 | 381.381 | 206.126 | 297.943 | 326.372 | 392.527 | 258.502 | 304.279 | 303.223 | 294.751 | 146.865 | 189.619 | 222.279 | 236.562 | 222.554 | 169.716 | 137.092 | 155.541 | 170.56 | 150.883 | 99.175 | 110.748 | 122.857 | 106.696 | 103.165 |
| SG&A
| 193.952 | -6.185 | 110.984 | 132.051 | 281.883 | 212.162 | 389.58 | 212.441 | 441.209 | 452.364 | 485.462 | 192.01 | 335.647 | 278.361 | 476.423 | 241.422 | 337.984 | 249.066 | 319.85 | 141.661 | 205.256 | 196.722 | 257.483 | 218.741 | 183.792 | 104.752 | 174.38 | 115.765 | 177.653 | 36.055 | 124.93 | 111.987 | 129.755 | 57.179 |
| Other Expenses
| -10.776 | 339.535 | 0 | -3.133 | -2.493 | -12.117 | -0.996 | 42.037 | 1.33 | 22.507 | 18.421 | 23.766 | 4.843 | 90.15 | 9.698 | 1.603 | -0.002 | 74.453 | -0.708 | 6.07 | -5.07 | 2.112 | 4.988 | -0.326 | 0.015 | 4.509 | 0.504 | 3.881 | -0.016 | -6.911 | 1.01 | 6.385 | 3.679 | 7.611 |
| Operating Expenses
| 219.818 | 444.694 | 169.088 | 205.039 | 347.009 | 539.641 | 342.928 | 392.077 | 479.562 | 547.476 | 501.561 | 264.391 | 373.327 | 497.604 | 427.01 | 307.886 | 369.442 | 454.014 | 301.69 | 201.54 | 223.812 | 303.081 | 273.446 | 257.911 | 208.914 | 196.929 | 202.01 | 214.547 | 181.153 | 157.158 | 146.676 | 159.87 | 132.817 | 153.06 |
| Operating Income
| 10.311 | -379.86 | -10.372 | -53.769 | 114.188 | -54.855 | 101.497 | 41.775 | 125.513 | 30.009 | 114.038 | 55.328 | 82.599 | -20.717 | 173.577 | 58.294 | 74.128 | -47.007 | 148.558 | 39.391 | 57.612 | -19.026 | 70.569 | 69.282 | 61.442 | 83.525 | 58.797 | 47.043 | 45.466 | 57.311 | 46.109 | 46.837 | 31.44 | 44.427 |
| Operating Income Ratio
| 0.027 | -1.805 | -0.032 | -0.19 | 0.183 | -0.084 | 0.174 | 0.076 | 0.175 | 0.045 | 0.161 | 0.142 | 0.16 | -0.038 | 0.248 | 0.133 | 0.144 | -0.098 | 0.273 | 0.127 | 0.17 | -0.043 | 0.169 | 0.159 | 0.183 | 0.241 | 0.186 | 0.119 | 0.123 | 0.167 | 0.126 | 0.121 | 0.111 | 0.123 |
| Total Other Income Expenses Net
| 49.813 | -0.737 | -292.493 | -20.174 | -2.493 | -12.117 | -0.996 | 42.037 | 1.33 | -2.591 | 18.421 | 23.766 | 4.843 | 66.19 | 9.698 | 1.603 | -0.002 | 74.453 | -0.708 | 6.07 | -5.07 | 2.112 | 4.988 | -0.326 | 0.015 | 4.509 | 0.504 | 3.881 | -0.016 | -6.911 | 1.01 | 5.57 | 3.679 | 7.316 |
| Income Before Tax
| 60.124 | -380.598 | -302.866 | -73.943 | 111.695 | -66.972 | 100.501 | 83.812 | 126.843 | 27.418 | 132.459 | 79.094 | 87.442 | 45.473 | 183.275 | 59.897 | 74.127 | 27.446 | 147.85 | 45.461 | 52.542 | -16.914 | 75.557 | 68.956 | 61.457 | 88.033 | 59.301 | 50.924 | 45.45 | 50.4 | 47.119 | 52.407 | 35.119 | 51.742 |
| Income Before Tax Ratio
| 0.159 | -1.809 | -0.945 | -0.261 | 0.179 | -0.102 | 0.172 | 0.152 | 0.177 | 0.041 | 0.187 | 0.203 | 0.17 | 0.083 | 0.262 | 0.137 | 0.144 | 0.057 | 0.272 | 0.146 | 0.155 | -0.038 | 0.181 | 0.158 | 0.183 | 0.254 | 0.188 | 0.128 | 0.122 | 0.147 | 0.128 | 0.135 | 0.124 | 0.143 |
| Income Tax Expense
| 6.678 | -83.335 | -2.387 | -9.49 | 16.208 | 40.59 | 31.316 | -1.983 | 22.467 | 12.063 | 27.59 | 10.92 | 13.744 | 16.483 | 35.993 | 10.449 | 6.432 | -0.089 | 31.783 | 8.622 | 9.345 | 8.327 | 15.028 | 10.866 | 12.307 | 13.278 | 7.644 | 8.351 | 6.75 | 4.059 | 9.386 | 11.19 | 5.591 | 6.034 |
| Net Income
| 56.588 | -293.5 | -292.997 | -54.054 | 100.512 | -97.339 | 77.016 | 93.831 | 111.106 | 24.719 | 111.36 | 74.81 | 79.793 | 18.617 | 170.338 | 49.92 | 68.041 | 29.01 | 116.144 | 37.204 | 43.252 | -24.08 | 60.521 | 58.093 | 49.152 | 74.916 | 51.802 | 42.807 | 38.699 | 46.601 | 39.224 | 41.222 | 29.649 | 46.239 |
| Net Income Ratio
| 0.15 | -1.395 | -0.914 | -0.191 | 0.161 | -0.149 | 0.132 | 0.171 | 0.155 | 0.037 | 0.157 | 0.192 | 0.155 | 0.034 | 0.243 | 0.114 | 0.132 | 0.06 | 0.214 | 0.119 | 0.127 | -0.054 | 0.145 | 0.133 | 0.146 | 0.216 | 0.164 | 0.108 | 0.104 | 0.136 | 0.107 | 0.107 | 0.104 | 0.128 |
| EPS
| 0.13 | -0.65 | -0.65 | -0.12 | 0.22 | -0.25 | 0.17 | 0.22 | 0.26 | 0.067 | 0.27 | 0.18 | 0.19 | 0.044 | 0.39 | 0.12 | 0.16 | 0.066 | 0.27 | 0.087 | 0.1 | -0.057 | 0.14 | 0.14 | 0.11 | 0.17 | 0.12 | 0.096 | 0.089 | 0.13 | 0.12 | 0.13 | 0.092 | 0.14 |
| EPS Diluted
| 0.13 | -0.65 | -0.65 | -0.12 | 0.22 | -0.25 | 0.17 | 0.22 | 0.26 | 0.067 | 0.27 | 0.18 | 0.18 | 0.044 | 0.39 | 0.12 | 0.16 | 0.066 | 0.27 | 0.087 | 0.1 | -0.057 | 0.14 | 0.14 | 0.11 | 0.17 | 0.12 | 0.096 | 0.089 | 0.13 | 0.12 | 0.13 | 0.092 | 0.14 |
| EBITDA
| 76.705 | -371.008 | -298.237 | 0.314 | 158.67 | -28.456 | 156.012 | 135.359 | 180.974 | 49.079 | 135.353 | 106.504 | 114.482 | 98.811 | 217.685 | 80.072 | 95.522 | 36.999 | 148.911 | 57.953 | 61.945 | -7.006 | 85.963 | 79.549 | 74.032 | 105.976 | 64.147 | 59.807 | 48.743 | 60.604 | 51.771 | 64.695 | 35.682 | 70.634 |
| EBITDA Ratio
| 0.203 | -1.763 | -0.93 | 0.001 | 0.255 | -0.044 | 0.267 | 0.246 | 0.253 | 0.074 | 0.191 | 0.274 | 0.222 | 0.181 | 0.311 | 0.183 | 0.186 | 0.077 | 0.274 | 0.186 | 0.183 | -0.016 | 0.206 | 0.182 | 0.22 | 0.306 | 0.203 | 0.151 | 0.131 | 0.177 | 0.141 | 0.167 | 0.126 | 0.195 |